Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer

Reham Helwa, Liv B Gansmo, Merete Bjørnslett, Mari Kyllesø Halle, Henrica M J Werner, Pål Romundstad, Kristian Hveem, Lars Vatten, Anne Dørum, Per E Lønning, Stian Knappskog*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Web of Science)
Original languageEnglish
Pages (from-to)302-308
Number of pages7
JournalBiomarkers
Volume26
Issue number4
DOIs
Publication statusPublished - 19 May 2021

Keywords

  • Aged
  • Alleles
  • Case-Control Studies
  • Cohort Studies
  • Endometrial Neoplasms/diagnosis
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease/genetics
  • Genome-Wide Association Study/methods
  • Genotype
  • Humans
  • Linkage Disequilibrium
  • Middle Aged
  • Ovarian Neoplasms/diagnosis
  • Polymorphism, Single Nucleotide
  • Promoter Regions, Genetic/genetics
  • Proto-Oncogene Proteins c-mdm2/genetics
  • ovarian cancer
  • polymorphism
  • POLYMORPHISM
  • SNP
  • MDM2
  • endometrial cancer
  • risk

Cite this